Media Center
Our industry experts, business perspectives and insights are regularly published in prominent news publications.
Home / Media Center
Featured News Releases
TRINITY LIFE SCIENCES’ AI ALGORITHM ACCURATELY PREDICTS REVENUE OUTCOMES FOR OVER 90% OF U.S. DRUG LAUNCHES FAR EXCEEDING WALL STREET ANALYST ATTEMPTS
April 17, 2025
HEALTH EQUITY CONSIDERATIONS AS A DIFFERENTIATOR IN VALUE NARRATIVES PROVIDE OPPORTUNITY FOR LIFE SCIENCES’ GLOBAL HTA SUBMISSIONS
April 15, 2025
ANALYSIS OF DISPARATE HEALTH TECHNOLOGY ASSESSMENT LANDSCAPE TRANSFORMED WITH GENERATIVE AI TOOLS
March 11, 2025
Trinity in the News
Fierce Pharma
Argenx’s Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts
March 12, 2025
Industry Impact Series
Trinity Life Sciences is proud to announce our Industry Impact Series, a thought leadership series that identifies key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The focus of Trinity’s Industry Impact Series in 2024 explores how biopharma can reimagine the blockbuster and translate scientific innovation to commercial success. The series is designed to leverage the totality of Trinity’s background as a life sciences partner supporting strategy, insights and analytics across the product lifecycle.
Trending at Trinity
Our Latest Intelligence
Blog
Seizing the Storm: Why Pharma Must Plan, Not Panic in Trump’s Second Term
The first 100 days of President Trump’s return to the White House have been anything but ordinary. With a true “Flood the Zone” strategy, there has been a flurry of executive orders, leadership reshuffles, and a re-assertion of executive power, which has signaled the administration is interested in seeing what policy options can “stick.” While […]
Read More
Webinars
The NRDL Conundrum: Balancing Between Access and Pricing for Innovation
May 21, 2025 | 1:00 – 1:45 PM ET
What key insights emerged from the 2024 China National Reimbursement Drug List (NRDL) negotiations and how can they inform strategic go-to-market planning for innovative therapies? In the 2024 NRDL negotiations, only 28% of submitted products passed expert review, significantly raising the bar for entering pricing negotiations.
Sign Up Now
Blog
Navigating the CRM Split: Generating Buy‑In
The transition to a new CRM system is more than just a technical migration; it’s a strategic choice that requires careful consideration and a strong point of view on what your organization needs for success. To navigate the CRM transition necessitated by the Salesforce-Veeva split, it’s crucial to generate buy-in from account and field teams […]
Read More
Media Resources
Logos
Brand Guidelines
Trinity One-Pager
Media Contact
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com